STRS Ohio’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-3,780
| Closed | -$39K | – | 2047 |
|
|
2023
Q1 | $39K | Hold |
3,780
| – | – | ﹤0.01% | 1812 |
|
|
2022
Q4 | $128K | Hold |
3,780
| – | – | ﹤0.01% | 1687 |
|
|
2022
Q3 | $181K | Hold |
3,780
| – | – | ﹤0.01% | 1626 |
|
|
2022
Q2 | $215K | Buy |
+3,780
| New | +$238K | ﹤0.01% | 1588 |
|
|
2020
Q4 | – | Sell |
-150
| Closed | -$37K | – | 2242 |
|
|
2020
Q3 | $37K | Hold |
150
| – | – | ﹤0.01% | 2016 |
|
|
2020
Q2 | $52K | Hold |
150
| – | – | ﹤0.01% | 1908 |
|
|
2020
Q1 | $40K | Hold |
150
| – | – | ﹤0.01% | 1815 |
|
|
2019
Q4 | $48K | Hold |
150
| – | – | ﹤0.01% | 1902 |
|
|
2019
Q3 | $41K | Hold |
150
| – | – | ﹤0.01% | 1907 |
|
|
2019
Q2 | $80K | Sell |
150
-820
| -85% | -$411K | ﹤0.01% | 1849 |
|
|
2019
Q1 | $488K | Buy |
970
+165
| +20% | +$97.8K | ﹤0.01% | 1296 |
|
|
2018
Q4 | $396K | Sell |
805
-1,140
| -59% | -$688K | ﹤0.01% | 1372 |
|
|
2018
Q3 | $1.78M | Buy |
1,945
+432
| +29% | +$369K | 0.01% | 678 |
|
|
2018
Q2 | $1.11M | Sell |
1,513
-934
| -38% | -$1.08M | ﹤0.01% | 846 |
|
|
2018
Q1 | $3.9M | Buy |
2,447
+347
| +17% | +$447K | 0.02% | 522 |
|
|
2017
Q4 | $1.88M | Buy |
2,100
+1,007
| +92% | +$596K | 0.01% | 636 |
|
|
2017
Q3 | $393K | Buy |
1,093
+153
| +16% | +$47.9K | ﹤0.01% | 1413 |
|
|
2017
Q2 | $275K | Sell |
940
-300
| -24% | -$86.7K | ﹤0.01% | 1466 |
|
|
2017
Q1 | $436K | Buy |
+1,240
| New | +$279K | ﹤0.01% | 1367 |
|
|
2016
Q4 | – | Sell |
-613
| Closed | -$158K | – | 1974 |
|
|
2016
Q3 | $158K | Buy |
613
+173
| +39% | +$44.5K | ﹤0.01% | 1588 |
|
|
2016
Q2 | $93K | Buy |
440
+220
| +100% | +$49.2K | ﹤0.01% | 1693 |
|
|
2016
Q1 | $45K | Sell |
220
-287
| -57% | -$55.1K | ﹤0.01% | 1775 |
|
|
2015
Q4 | $128K | Sell |
507
-351
| -41% | -$72.2K | ﹤0.01% | 1618 |
|
|
2015
Q3 | $141K | Hold |
858
| – | – | ﹤0.01% | 1598 |
|
|
2015
Q2 | $160K | Hold |
858
| – | – | ﹤0.01% | 1608 |
|
|
2015
Q1 | $141K | Sell |
858
-260
| -23% | -$53.4K | ﹤0.01% | 1554 |
|
|
2014
Q4 | $260K | Buy |
+1,118
| New | +$239K | ﹤0.01% | 1382 |
|
|
2013
Q4 | – | Sell |
-87
| Closed | -$14K | – | 1793 |
|
|
2013
Q3 | $14K | Buy |
+87
| New | +$16.1K | ﹤0.01% | 1800 |
|
Other funds holding NKTR
DTC
MAM
SCM
STRS Ohio's NKTR Position: Q2 2023 in Review
STRS Ohio sold out of Nektar Therapeutics (NKTR) in Q2 2023, closing a stake of 3,780 shares — an estimated $39K sold.
STRS Ohio first reported a position in NKTR in Q3 2013 and held it in 28 quarters. The position peaked at $3.9M in Q1 2018. 146 funds tracked by Wall St. Rank hold NKTR as of Q2 2023.
- STRS Ohio reported no remaining Nektar Therapeutics position as of Q2 2023 after selling out during the quarter.
- STRS Ohio sold 3,780 Nektar Therapeutics shares in Q2 2023, an estimated $39K.
- STRS Ohio first reported a position in Nektar Therapeutics in Q3 2013 and held it in 28 quarters.
- STRS Ohio's Nektar Therapeutics position peaked at $3.9M in Q1 2018.
- 146 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2023.
Based on STRS Ohio's 13F filing for Q2 2023, filed 31 Jul 2023.